 MONMOUTH JUNCTION, N.J., March 12, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO, a critical care immunotherapy leader commercializing its CytoSorb blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announces its participation the Oppenheimer 31st Annual Healthcare Conference. 